---
schema_version: "secwatch.filing_event.v1"
accession: "0001601485-24-000006"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2024-01-16T23:59:59+00:00"
generated_at: "2026-06-06T23:15:11.405337+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Elicio raises ~$4.9M from ATM equity sales since Q3 2023

## Summary
- Issued and sold 584,170 shares under at-the-market program since September 30, 2023.
- Net proceeds of approximately $4.89 million after deducting sales commissions.
- Original ATM program authorized up to $21.0 million in aggregate offering price.
- Program is ongoing with Stifel and Virtu Americas LLC as agents.

## SEC filing metadata
- accession: 0001601485-24-000006
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2024-01-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000006/0001601485-24-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000006/angn-20240116.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601485-24-000006
- JSON: https://secwatch.observer/filing/0001601485-24-000006.json
- Plain text: https://secwatch.observer/filing/0001601485-24-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.